BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11163665)

  • 1. Heat shock protein-peptide complexes elicit cytotoxic T-lymphocyte and antibody responses specific for bovine herpesvirus 1.
    Navaratnam M; Deshpande MS; Hariharan MJ; Zatechka DS; Srikumaran S
    Vaccine; 2001 Jan; 19(11-12):1425-34. PubMed ID: 11163665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1.
    Zatechka DS; Hegde NR; Hariharan K; Srikumaran S
    Vaccine; 1999 Feb; 17(7-8):686-94. PubMed ID: 10067674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization.
    Deshpande MS; Ambagala TC; Hegde NR; Hariharan MJ; Navaratnam M; Srikumaran S
    Vaccine; 2002 Nov; 20(31-32):3744-51. PubMed ID: 12399204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine lymphocyte antigen-A11--specific peptide motif as a means to identify cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1.
    Hegde NR; Deshpande MS; Godson DL; Babiuk LA; Srikumaran S
    Viral Immunol; 1999; 12(2):149-61. PubMed ID: 10413361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle.
    Huang Y; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2005 Apr; 86(Pt 4):887-898. PubMed ID: 15784883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
    Arnold D; Faath S; Rammensee H; Schild H
    J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine monoclonal anti-idiotypes induce antibodies specific for a synthetic peptide bearing a neutralizing epitope of bovine herpesvirus 1 glycoprotein gI (gB).
    Hariharan K; Hariharan MJ; Zamb TJ; Krueger RJ; Srikumaran S
    J Immunol; 1991 May; 146(10):3489-95. PubMed ID: 1709196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of potential cytotoxic T lymphocyte epitopes of bovine herpesvirus 1 based on allele-specific peptide motifs and proteolytic cleavage specificities.
    Hegde NR; Srikumaran S
    Virus Genes; 1996; 13(2):121-33. PubMed ID: 8972566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of antigenic variation between the glycoproteins C of respiratory bovine herpesvirus 1 (BHV-1) and neurovirulent BHV-5.
    Chowdhury SI
    Virology; 1995 Nov; 213(2):558-68. PubMed ID: 7491780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-presentation of human melanoma peptide antigen MART-1 to CTLs from in vitro reconstituted gp96/MART-1 complexes.
    Staib F; Distler M; Bethke K; Schmitt U; Galle PR; Heike M
    Cancer Immun; 2004 Apr; 4():3. PubMed ID: 15086273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of different target glycoproteins for bovine herpes virus type 1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation.
    Denis M; Slaoui M; Keil G; Babiuk LA; Ernst E; Pastoret PP; Thiry E
    Immunology; 1993 Jan; 78(1):7-13. PubMed ID: 8382189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polynucleotide vaccines in animals: enhancing and modulating responses.
    Lewis PJ; Cox GJ; van Drunen Littel-van den Hurk S; Babiuk LA
    Vaccine; 1997 Jun; 15(8):861-4. PubMed ID: 9234534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast-secreted bovine herpesvirus type 1 glycoprotein D has authentic conformational structure and immunogenicity.
    Zhu X; Wu S; Letchworth GJ
    Vaccine; 1997; 15(6-7):679-88. PubMed ID: 9178470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
    Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
    J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bovine immune responses to affinity-purified bovine herpesvirus-1 antiidiotypes and glycoproteins.
    Orten DJ; Xue W; van Drunen Littel-van den hurk S; Abdelmagid OY; Reddy DN; Campos M; Babiuk LA; Blecha F; Minocha HC
    Viral Immunol; 1993; 6(2):109-17. PubMed ID: 8216712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine mapping of bovine herpesvirus-1 (BHV-1) glycoprotein D (gD) neutralizing epitopes by type-specific monoclonal antibodies and sequence comparison with BHV-5 gD.
    Abdelmagid OY; Minocha HC; Collins JK; Chowdhury SI
    Virology; 1995 Jan; 206(1):242-53. PubMed ID: 7530392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cytotoxic T cells in vitro by recombinant gp96 fusion proteins irrespective of the 'fused' antigenic peptide sequence.
    Moré S; Breloer M; Fleischer B; von Bonin A
    Immunol Lett; 1999 Aug; 69(2):275-82. PubMed ID: 10482363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
    Lammert E; Arnold D; Rammensee HG; Schild H
    Eur J Immunol; 1996 Apr; 26(4):875-9. PubMed ID: 8625982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.